APA (7th ed.) Citation

Lindsay, C., Musgaard, M., Russell, A. J., & Sitsapesan, R. (2022). Statin activation of skeletal ryanodine receptors (RyR1) is a class effect but separable from HMG‐CoA reductase inhibition. British Journal of Pharmacology, 179(21), 4941. https://doi.org/10.1111/bph.15893

Chicago Style (17th ed.) Citation

Lindsay, Chris, Maria Musgaard, Angela J. Russell, and Rebecca Sitsapesan. "Statin Activation of Skeletal Ryanodine Receptors (RyR1) Is a Class Effect but Separable from HMG‐CoA Reductase Inhibition." British Journal of Pharmacology 179, no. 21 (2022): 4941. https://doi.org/10.1111/bph.15893.

MLA (9th ed.) Citation

Lindsay, Chris, et al. "Statin Activation of Skeletal Ryanodine Receptors (RyR1) Is a Class Effect but Separable from HMG‐CoA Reductase Inhibition." British Journal of Pharmacology, vol. 179, no. 21, 2022, p. 4941, https://doi.org/10.1111/bph.15893.